As of 2024-12-14, the Intrinsic Value of Bausch Health Companies Inc (BHC.TO) is
9.89 CAD. This BHC.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 11.01 CAD, the upside of Bausch Health Companies Inc is
-10.20%.
The range of the Intrinsic Value is (20.92) - 122.85 CAD
BHC.TO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(20.92) - 122.85 |
9.89 |
-10.2% |
| DCF (Growth 10y) |
(17.58) - 116.80 |
11.57 |
5.1% |
| DCF (EBITDA 5y) |
(41.35) - (26.65) |
(1,747.81) |
-123450.0% |
| DCF (EBITDA 10y) |
(31.45) - (10.77) |
(1,747.81) |
-123450.0% |
| Fair Value |
-3.43 - -3.43 |
-3.43 |
-131.12% |
| P/E |
(12.07) - (16.43) |
(13.31) |
-220.9% |
| EV/EBITDA |
(18.99) - 16.15 |
(1.89) |
-117.2% |
| EPV |
51.11 - 144.57 |
97.84 |
788.6% |
| DDM - Stable |
(3.49) - (11.51) |
(7.50) |
-168.1% |
| DDM - Multi |
(5.34) - (14.63) |
(7.92) |
-172.0% |
BHC.TO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
4,049.51 |
| Beta |
0.57 |
| Outstanding shares (mil) |
367.80 |
| Enterprise Value (mil) |
33,481.16 |
| Market risk premium |
5.10% |
| Cost of Equity |
11.56% |
| Cost of Debt |
10.69% |
| WACC |
6.93% |